CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 91 enrolled
Drug / intervention
Cognitive behavioral therapy (CBT)behavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04887155
NCT04887155N/ACompleted

Mobile-enhanced Transdiagnostic Group Treatment for Adolescents at Risk for Severe Mood Disorders

University of California, Los Angeles·interventional·Posted May 14, 2021·Updated May 22, 2025

In Brief

A clinical study evaluating Cognitive behavioral therapy (CBT) for Adolescents and Mood Disorders. Completed, enrolled 91 participants across 1 site.

Detailed Summary

Although cognitive-behavioral therapy (CBT) has shown efficacy in reducing symptoms and rates of mood relapse in adolescents at high risk for severe mood disorders (SMD; i.e., bipolar I/II disorder and recurrent or unremitting major depression), a significant limitation to the CBT's efficacy is the low rate of participant adherence to the prescribed between-session homework tasks. Mobile health applications have the potential to improve adherence to and acceptance of treatment through embedded treatment content, skill-practice, thought and symptom monitoring, all of which are facilitated by reward contingencies and notifications. This study examines whether a mobile application-enhanced CBT can improve participant adherence and treatment acceptance for adolescents at high risk for SMD.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMay 14, 2021
Enrollment StartAug 30, 2021
Primary CompletionMar 15, 2024
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 5.1 years ago

Interventions

Cognitive behavioral therapy (CBT)behavioral

Group-based transdiagnostic cognitive-behavioral treatment